Elopak expects full-year EBITDA margin around 15%, excluding insurance claim timing effects

• Elopak expects full-year 2026 revenue in line with its current run rate.
• The full-year EBITDA margin is forecast at around 15%, excluding timing effects related to insurance claims.
• Third-quarter revenue rose 6.5% to EUR 308.4 million; EBITDA reached EUR 51.9 million, with a 16.8% margin.
• Managing raw material costs in EMEA and operational challenges in the Americas remains a priority.
• Targets for 2028 include annual organic revenue growth of 4-6% and an EBITDA margin of 15-17%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elopak ASA published the original content used to generate this news brief on October 27, 2026, and is solely responsible for the information contained therein.